BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32176374)

  • 1. Initial Information on a Novel Nicotine Product.
    Plurphanswat N; Hughes JR; Fagerström K; Rodu B
    Am J Addict; 2020 Jul; 29(4):279-286. PubMed ID: 32176374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use, marketing, and appeal of oral nicotine products among adolescents, young adults, and adults.
    Gaiha SM; Lin C; Lempert LK; Halpern-Felsher B
    Addict Behav; 2023 May; 140():107632. PubMed ID: 36731224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the public health impact had tobacco-free nicotine pouches been introduced into the US in 2000.
    Lee PN; Fry JS; Ljung T
    BMC Public Health; 2022 May; 22(1):1025. PubMed ID: 35597944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of Proposed Relative-Risk Warning Labels for Snus With Perceptions and Behavioral Intentions Among Tobacco Users and Nonusers.
    Rodu B; Plurphanswat N; Hughes JR; Fagerström K
    Nicotine Tob Res; 2016 May; 18(5):809-16. PubMed ID: 26253616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs).
    Back S; Masser AE; Rutqvist LE; Lindholm J
    BMC Chem; 2023 Mar; 17(1):9. PubMed ID: 36869349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic Comparison of a Novel Non-tobacco-Based Nicotine Pouch (ZYN) With Conventional, Tobacco-Based Swedish Snus and American Moist Snuff.
    Lunell E; Fagerström K; Hughes J; Pendrill R
    Nicotine Tob Res; 2020 Oct; 22(10):1757-1763. PubMed ID: 32319528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polytobacco Use and Nicotine Dependence Symptoms Among US Adults, 2012-2014.
    Sung HY; Wang Y; Yao T; Lightwood J; Max W
    Nicotine Tob Res; 2018 Aug; 20(suppl_1):S88-S98. PubMed ID: 30125019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine pouch marketing strategies in the USA: an analysis of Zyn, On! and Velo.
    Duan Z; Henriksen L; Vallone D; Rath JM; Evans WD; Romm KF; Wysota C; Berg CJ
    Tob Control; 2024 Feb; 33(2):154-163. PubMed ID: 35817549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Young or adult users of multiple tobacco/nicotine products urgently need to be informed of meaningful differences in product risks.
    Kozlowski LT; Sweanor DT
    Addict Behav; 2018 Jan; 76():376-381. PubMed ID: 28148394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the nicotine skin patch by smokers in 20 communities in the United States, 1992-1993.
    Cummings KM; Hyland A; Ockene JK; Hymowitz N; Manley M
    Tob Control; 1997; 6 Suppl 2(Suppl 2):S63-70. PubMed ID: 9583655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Past Year Quit Attempts and Use of Cessation Resources Among Cigarette-Only Smokers and Cigarette Smokers Who Use Other Tobacco Products.
    Schauer GL; Pederson LL; Malarcher AM
    Nicotine Tob Res; 2016 Jan; 18(1):41-7. PubMed ID: 25744953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Other Combustible Products: Prevalence and Correlates of Little Cigar/Cigarillo Use Among Cigarette Smokers.
    Cohn A; Cobb CO; Niaura RS; Richardson A
    Nicotine Tob Res; 2015 Dec; 17(12):1473-81. PubMed ID: 25634932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavored Tobacco Product Use and Its Association With Indicators of Tobacco Dependence Among US Adults, 2014-2015.
    Odani S; Armour B; Agaku IT
    Nicotine Tob Res; 2020 May; 22(6):1004-1015. PubMed ID: 31180498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flavored Tobacco Product Use in Youth and Adults: Findings From the First Wave of the PATH Study (2013-2014).
    Villanti AC; Johnson AL; Ambrose BK; Cummings KM; Stanton CA; Rose SW; Feirman SP; Tworek C; Glasser AM; Pearson JL; Cohn AM; Conway KP; Niaura RS; Bansal-Travers M; Hyland A
    Am J Prev Med; 2017 Aug; 53(2):139-151. PubMed ID: 28318902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smokers' behavioral intentions in response to a low-nicotine cigarette policy.
    Patel M; Cuccia AF; Czaplicki L; Donovan EM; Simard B; Pitzer L; Hair EC; Schillo BA; Vallone DM
    Drug Alcohol Depend; 2019 Dec; 205():107645. PubMed ID: 31704376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dependence levels in users of electronic cigarettes, nicotine gums and tobacco cigarettes.
    Etter JF; Eissenberg T
    Drug Alcohol Depend; 2015 Feb; 147():68-75. PubMed ID: 25561385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smokeless tobacco use among men in the United States, 2000 and 2005.
    Rodu B; Cole P
    J Oral Pathol Med; 2009 Aug; 38(7):545-50. PubMed ID: 19453847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching.
    Hatsukami DK; Severson H; Anderson A; Vogel RI; Jensen J; Broadbent B; Murphy SE; Carmella S; Hecht SS
    Tob Control; 2016 May; 25(3):267-74. PubMed ID: 25991608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of snus in initiation and cessation of tobacco smoking in Sweden.
    Ramström LM; Foulds J
    Tob Control; 2006 Jun; 15(3):210-4. PubMed ID: 16728752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a Measure of Normative Beliefs About Smokeless Tobacco Use.
    Adkison SE; O'Connor RJ; Bansal-Travers M; Cummings KM; Rees VW; Hatsukami DK
    Nicotine Tob Res; 2016 May; 18(5):801-8. PubMed ID: 26187390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.